NO814294L - 1,2-dihydro-5-(pyridinyl)nikotinamidderivater og fremgangsmaate for deres fremstilling - Google Patents
1,2-dihydro-5-(pyridinyl)nikotinamidderivater og fremgangsmaate for deres fremstillingInfo
- Publication number
- NO814294L NO814294L NO814294A NO814294A NO814294L NO 814294 L NO814294 L NO 814294L NO 814294 A NO814294 A NO 814294A NO 814294 A NO814294 A NO 814294A NO 814294 L NO814294 L NO 814294L
- Authority
- NO
- Norway
- Prior art keywords
- pyridinyl
- dihydro
- oxo
- hydroxy
- nicotinimidamide
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 18
- 238000000034 method Methods 0.000 title claims description 16
- 239000002253 acid Substances 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- FBTHQHDEQOMDGA-UHFFFAOYSA-N N'-hydroxy-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carboximidamide Chemical compound N1C(=O)C(C(=N)NO)=CC(C=2C=CN=CC=2)=C1 FBTHQHDEQOMDGA-UHFFFAOYSA-N 0.000 claims description 8
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 229920000137 polyphosphoric acid Polymers 0.000 claims description 5
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000012458 free base Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- -1 alkyl ketone Chemical class 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000003540 papillary muscle Anatomy 0.000 description 6
- FVGUUJNEJJPLCS-UHFFFAOYSA-N pyridine-3-carboximidamide Chemical compound NC(=N)C1=CC=CN=C1 FVGUUJNEJJPLCS-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- RNLQIBCLLYYYFJ-UHFFFAOYSA-N amrinone Chemical compound N1C(=O)C(N)=CC(C=2C=CN=CC=2)=C1 RNLQIBCLLYYYFJ-UHFFFAOYSA-N 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000008602 contraction Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000004165 myocardium Anatomy 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000001746 atrial effect Effects 0.000 description 3
- 239000003701 inert diluent Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- NSOXQPXRTUGNOI-UHFFFAOYSA-N 1,6-diethyl-n'-hydroxy-2-oxo-5-pyridin-4-ylpyridine-3-carboximidamide Chemical compound C1=C(C(=N)NO)C(=O)N(CC)C(CC)=C1C1=CC=NC=C1 NSOXQPXRTUGNOI-UHFFFAOYSA-N 0.000 description 2
- KWHBIWAEVLEADF-UHFFFAOYSA-N 1-ethyl-n'-hydroxy-6-methyl-2-oxo-5-pyridin-4-ylpyridine-3-carboximidamide Chemical compound C1=C(\C(N)=N/O)C(=O)N(CC)C(C)=C1C1=CC=NC=C1 KWHBIWAEVLEADF-UHFFFAOYSA-N 0.000 description 2
- GZPHSAQLYPIAIN-UHFFFAOYSA-N 3-pyridinecarbonitrile Chemical compound N#CC1=CC=CN=C1 GZPHSAQLYPIAIN-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NKIIJNIYSVGMAS-UHFFFAOYSA-N N'-hydroxy-2-oxo-6-pentyl-5-pyridin-4-yl-1H-pyridine-3-carboximidamide Chemical compound N1C(=O)C(C(=N)NO)=CC(C=2C=CN=CC=2)=C1CCCCC NKIIJNIYSVGMAS-UHFFFAOYSA-N 0.000 description 2
- YQPXXKZJHHQELD-UHFFFAOYSA-N N'-hydroxy-6-(2-methylpropyl)-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carboximidamide Chemical compound ONC(C=1C(NC(=C(C1)C1=CC=NC=C1)CC(C)C)=O)=N YQPXXKZJHHQELD-UHFFFAOYSA-N 0.000 description 2
- RMNIANPUMCICDO-UHFFFAOYSA-N N'-hydroxy-6-methyl-2-oxo-5-pyridin-3-yl-1H-pyridine-3-carboximidamide Chemical compound ONC(C=1C(NC(=C(C1)C=1C=NC=CC1)C)=O)=N RMNIANPUMCICDO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- REVCBMSBHVTBLR-UHFFFAOYSA-N 1,6-diethyl-2-oxo-5-pyridin-4-ylpyridine-3-carbonitrile Chemical compound C1=C(C#N)C(=O)N(CC)C(CC)=C1C1=CC=NC=C1 REVCBMSBHVTBLR-UHFFFAOYSA-N 0.000 description 1
- CQVKMVQRSNNAGO-UHFFFAOYSA-N 2-[4-formyl-3-methyl-n-(2-methylsulfonyloxyethyl)anilino]ethyl methanesulfonate Chemical compound CC1=CC(N(CCOS(C)(=O)=O)CCOS(C)(=O)=O)=CC=C1C=O CQVKMVQRSNNAGO-UHFFFAOYSA-N 0.000 description 1
- AKKQMYMAJMINPN-UHFFFAOYSA-N 2-oxo-5-pyridin-2-yl-1h-pyridine-3-carboxamide Chemical class N1C(=O)C(C(=O)N)=CC(C=2N=CC=CC=2)=C1 AKKQMYMAJMINPN-UHFFFAOYSA-N 0.000 description 1
- SEQOYYYZFNJQSV-UHFFFAOYSA-N 2-oxo-5-pyridin-4-yl-1h-pyridine-3-carbonitrile Chemical compound C1=C(C#N)C(=O)NC=C1C1=CC=NC=C1 SEQOYYYZFNJQSV-UHFFFAOYSA-N 0.000 description 1
- DOMBTIDADHSAMH-UHFFFAOYSA-N 2-oxo-6-pentyl-5-pyridin-4-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1CCCCC DOMBTIDADHSAMH-UHFFFAOYSA-N 0.000 description 1
- BHXNMSPNBMWKDY-UHFFFAOYSA-N 2-oxo-6-propan-2-yl-5-pyridin-4-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1C(C)C BHXNMSPNBMWKDY-UHFFFAOYSA-N 0.000 description 1
- YPGVFYQQZUFHDD-UHFFFAOYSA-N 3-amino-1,6-diethyl-5-pyridin-4-ylpyridin-2-one Chemical compound C1=C(N)C(=O)N(CC)C(CC)=C1C1=CC=NC=C1 YPGVFYQQZUFHDD-UHFFFAOYSA-N 0.000 description 1
- OTIZLYDEBSAMGZ-UHFFFAOYSA-N 3-amino-5-pyridin-2-yl-1h-pyridin-2-one Chemical class N1C(=O)C(N)=CC(C=2N=CC=CC=2)=C1 OTIZLYDEBSAMGZ-UHFFFAOYSA-N 0.000 description 1
- SSAQUOGAZLHUIU-UHFFFAOYSA-N 3-amino-6-(2-methylpropyl)-5-pyridin-4-yl-1h-pyridin-2-one Chemical compound N1C(=O)C(N)=CC(C=2C=CN=CC=2)=C1CC(C)C SSAQUOGAZLHUIU-UHFFFAOYSA-N 0.000 description 1
- LSUGUGZWFPGJAH-UHFFFAOYSA-N 3-amino-6-butyl-5-pyridin-4-yl-1h-pyridin-2-one Chemical compound N1C(=O)C(N)=CC(C=2C=CN=CC=2)=C1CCCC LSUGUGZWFPGJAH-UHFFFAOYSA-N 0.000 description 1
- PYKYMHPQTHIYCV-UHFFFAOYSA-N 3-amino-6-ethyl-1-(2-hydroxyethyl)-5-pyridin-4-ylpyridin-2-one Chemical compound C1=C(N)C(=O)N(CCO)C(CC)=C1C1=CC=NC=C1 PYKYMHPQTHIYCV-UHFFFAOYSA-N 0.000 description 1
- KPZGFZWENZHROE-UHFFFAOYSA-N 3-amino-6-ethyl-5-(2-methylpyridin-4-yl)-1h-pyridin-2-one Chemical compound N1C(=O)C(N)=CC(C=2C=C(C)N=CC=2)=C1CC KPZGFZWENZHROE-UHFFFAOYSA-N 0.000 description 1
- WMEPMKSZIPJHKV-UHFFFAOYSA-N 3-amino-6-ethyl-5-pyridin-3-yl-1h-pyridin-2-one Chemical compound N1C(=O)C(N)=CC(C=2C=NC=CC=2)=C1CC WMEPMKSZIPJHKV-UHFFFAOYSA-N 0.000 description 1
- SUTIGALCVBIWGD-UHFFFAOYSA-N 3-amino-6-pentyl-5-pyridin-4-yl-1h-pyridin-2-one Chemical compound N1C(=O)C(N)=CC(C=2C=CN=CC=2)=C1CCCCC SUTIGALCVBIWGD-UHFFFAOYSA-N 0.000 description 1
- OORDIDZIWSYBRI-UHFFFAOYSA-N 3-amino-6-propan-2-yl-5-pyridin-4-yl-1h-pyridin-2-one Chemical compound N1C(=O)C(N)=CC(C=2C=CN=CC=2)=C1C(C)C OORDIDZIWSYBRI-UHFFFAOYSA-N 0.000 description 1
- HLHPEGOIDMHGCX-UHFFFAOYSA-N 5-pyridin-2-yl-1,2-dihydropyridine-3-carboxamide Chemical class N1=C(C=CC=C1)C1=CNCC(C(=O)N)=C1 HLHPEGOIDMHGCX-UHFFFAOYSA-N 0.000 description 1
- IYZZLZWWNMGEFT-UHFFFAOYSA-N 6-(2-methylpropyl)-2-oxo-5-pyridin-4-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1CC(C)C IYZZLZWWNMGEFT-UHFFFAOYSA-N 0.000 description 1
- DYBRWHHEPOFFNG-UHFFFAOYSA-N 6-butyl-2-oxo-5-pyridin-4-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1CCCC DYBRWHHEPOFFNG-UHFFFAOYSA-N 0.000 description 1
- CZMQLZUNDRXNIL-UHFFFAOYSA-N 6-butyl-N'-hydroxy-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carboximidamide Chemical compound N1C(=O)C(C(=N)NO)=CC(C=2C=CN=CC=2)=C1CCCC CZMQLZUNDRXNIL-UHFFFAOYSA-N 0.000 description 1
- BRMZDBKLVWCMHM-UHFFFAOYSA-N 6-ethyl-1-(2-hydroxyethyl)-2-oxo-5-pyridin-4-ylpyridine-3-carbonitrile Chemical compound C1=C(C#N)C(=O)N(CCO)C(CC)=C1C1=CC=NC=C1 BRMZDBKLVWCMHM-UHFFFAOYSA-N 0.000 description 1
- RFIJPDMIVQAFHX-UHFFFAOYSA-N 6-ethyl-2-oxo-5-pyridin-3-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=NC=CC=2)=C1CC RFIJPDMIVQAFHX-UHFFFAOYSA-N 0.000 description 1
- VROQJHXWYPWUTN-UHFFFAOYSA-N 6-ethyl-5-(2-methylpyridin-4-yl)-2-oxo-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=C(C)N=CC=2)=C1CC VROQJHXWYPWUTN-UHFFFAOYSA-N 0.000 description 1
- NUAYNRJEMOGBIH-UHFFFAOYSA-N 6-ethyl-N'-hydroxy-2-oxo-5-pyridin-3-yl-1H-pyridine-3-carboximidamide Chemical compound ONC(C=1C(NC(=C(C1)C=1C=NC=CC1)CC)=O)=N NUAYNRJEMOGBIH-UHFFFAOYSA-N 0.000 description 1
- PYKRFSUXWROQST-UHFFFAOYSA-N 6-ethyl-N'-hydroxy-5-(2-methylpyridin-4-yl)-2-oxo-1H-pyridine-3-carboximidamide Chemical compound ONC(C=1C(NC(=C(C1)C1=CC(=NC=C1)C)CC)=O)=N PYKRFSUXWROQST-UHFFFAOYSA-N 0.000 description 1
- HZPQADMBVGLGDL-UHFFFAOYSA-N 6-ethyl-n'-hydroxy-1-(2-hydroxyethyl)-2-oxo-5-pyridin-4-ylpyridine-3-carboximidamide Chemical compound C1=C(C(=N)NO)C(=O)N(CCO)C(CC)=C1C1=CC=NC=C1 HZPQADMBVGLGDL-UHFFFAOYSA-N 0.000 description 1
- HFXSLWPMSHEBFJ-UHFFFAOYSA-N 6-methyl-2-oxo-5-pyridin-3-yl-1h-pyridine-3-carbonitrile Chemical compound N1C(=O)C(C#N)=CC(C=2C=NC=CC=2)=C1C HFXSLWPMSHEBFJ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- QZYXCHQLBHCFCT-UHFFFAOYSA-N N'-hydroxy-2-oxo-6-propan-2-yl-5-pyridin-4-yl-1H-pyridine-3-carboximidamide Chemical compound ONC(C=1C(NC(=C(C1)C1=CC=NC=C1)C(C)C)=O)=N QZYXCHQLBHCFCT-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229960002105 amrinone Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical compound CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- AHNJTQYTRPXLLG-UHFFFAOYSA-N lithium;diethylazanide Chemical compound [Li+].CC[N-]CC AHNJTQYTRPXLLG-UHFFFAOYSA-N 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/218,616 US4305948A (en) | 1980-12-22 | 1980-12-22 | N-Hydroxy-1,2-dihydro-2-oxo-5-(pyridinyl)-nicotinimidamide and their cardiotonic use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO814294L true NO814294L (no) | 1982-06-23 |
Family
ID=22815795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO814294A NO814294L (no) | 1980-12-22 | 1981-12-16 | 1,2-dihydro-5-(pyridinyl)nikotinamidderivater og fremgangsmaate for deres fremstilling |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4305948A (es) |
| JP (1) | JPS57140767A (es) |
| AU (1) | AU7793981A (es) |
| BE (1) | BE891493A (es) |
| CA (1) | CA1175838A (es) |
| DE (1) | DE3150062A1 (es) |
| DK (1) | DK557681A (es) |
| ES (1) | ES8502434A1 (es) |
| FI (1) | FI813913L (es) |
| FR (1) | FR2496659A1 (es) |
| GB (1) | GB2089791B (es) |
| GR (1) | GR76987B (es) |
| IL (1) | IL64439A0 (es) |
| IT (1) | IT1142099B (es) |
| LU (1) | LU83840A1 (es) |
| NL (1) | NL8105667A (es) |
| NO (1) | NO814294L (es) |
| PT (1) | PT74114B (es) |
| SE (1) | SE8107551L (es) |
| ZA (1) | ZA818277B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4361569A (en) * | 1981-08-26 | 1982-11-30 | Sterling Drug Inc. | 3-(Hydroxy or hydroxymethyl)-6-methyl-5-(4-pyridinyl)-2(1H)-pyridinone and cardiotonic use thereof |
| US5212314A (en) * | 1983-11-03 | 1993-05-18 | Merrell Dow Pharmaceuticals Inc. | Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones |
| US4849522A (en) * | 1983-11-03 | 1989-07-18 | Merrell Dow Pharmaceuticals | Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones |
| ZA848428B (en) * | 1983-11-03 | 1985-06-26 | Merrell Pharma Inc | Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones |
| CN104326975A (zh) * | 2014-10-20 | 2015-02-04 | 郑州四环医药用品有限公司 | 一种高纯度米力农的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4004012A (en) * | 1975-10-14 | 1977-01-18 | Sterling Drug Inc. | 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones |
| US4072746A (en) * | 1975-10-14 | 1978-02-07 | Sterling Drug Inc. | 3-Amino-5-(pyridinyl)-2(1H)-pyridinones |
| NZ195564A (en) * | 1979-11-26 | 1983-09-30 | Sterling Drug Inc | 5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds |
-
1980
- 1980-12-22 US US06/218,616 patent/US4305948A/en not_active Expired - Lifetime
-
1981
- 1981-11-23 CA CA000390670A patent/CA1175838A/en not_active Expired
- 1981-11-27 AU AU77939/81A patent/AU7793981A/en not_active Abandoned
- 1981-11-30 ZA ZA818277A patent/ZA818277B/xx unknown
- 1981-12-02 IL IL64439A patent/IL64439A0/xx unknown
- 1981-12-02 GB GB8136374A patent/GB2089791B/en not_active Expired
- 1981-12-04 GR GR66684A patent/GR76987B/el unknown
- 1981-12-07 FI FI813913A patent/FI813913L/fi not_active Application Discontinuation
- 1981-12-11 PT PT74114A patent/PT74114B/pt unknown
- 1981-12-14 IT IT25585/81A patent/IT1142099B/it active
- 1981-12-15 FR FR8123458A patent/FR2496659A1/fr not_active Withdrawn
- 1981-12-16 NO NO814294A patent/NO814294L/no unknown
- 1981-12-16 ES ES508020A patent/ES8502434A1/es not_active Expired
- 1981-12-16 SE SE8107551A patent/SE8107551L/xx not_active Application Discontinuation
- 1981-12-16 NL NL8105667A patent/NL8105667A/nl not_active Application Discontinuation
- 1981-12-16 BE BE1/10374A patent/BE891493A/fr not_active IP Right Cessation
- 1981-12-16 DK DK557681A patent/DK557681A/da not_active Application Discontinuation
- 1981-12-17 LU LU83840A patent/LU83840A1/fr unknown
- 1981-12-17 DE DE19813150062 patent/DE3150062A1/de not_active Withdrawn
- 1981-12-17 JP JP56204485A patent/JPS57140767A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SE8107551L (sv) | 1982-06-23 |
| ES508020A0 (es) | 1985-01-01 |
| IL64439A0 (en) | 1982-03-31 |
| ZA818277B (en) | 1982-10-27 |
| IT8125585A0 (it) | 1981-12-14 |
| GB2089791A (en) | 1982-06-30 |
| JPS57140767A (en) | 1982-08-31 |
| NL8105667A (nl) | 1982-07-16 |
| GR76987B (es) | 1984-09-04 |
| GB2089791B (en) | 1984-08-30 |
| US4305948A (en) | 1981-12-15 |
| CA1175838A (en) | 1984-10-09 |
| AU7793981A (en) | 1982-07-01 |
| DK557681A (da) | 1982-06-23 |
| PT74114B (en) | 1983-06-06 |
| LU83840A1 (fr) | 1982-07-07 |
| IT1142099B (it) | 1986-10-08 |
| ES8502434A1 (es) | 1985-01-01 |
| FI813913L (fi) | 1982-06-23 |
| DE3150062A1 (de) | 1982-07-22 |
| BE891493A (fr) | 1982-06-16 |
| PT74114A (en) | 1982-01-01 |
| FR2496659A1 (fr) | 1982-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4107315A (en) | 5-(Pyridinyl)-2(1H)-pyridinones | |
| NO811041L (no) | Imidazopyridiner og fremgangsmaate til deres fremstilling | |
| JPS6032630B2 (ja) | ピリジニル−２（１ｈ）−ピリジノン類、その製法、及びそれからなる強心剤 | |
| NO823026L (no) | 2(1h)-pyridinoner og fremgangsmaate for deres fremstilling | |
| NO814294L (no) | 1,2-dihydro-5-(pyridinyl)nikotinamidderivater og fremgangsmaate for deres fremstilling | |
| NO852677L (no) | Fremgangsmaate for fremstilling av 1,6-naftyridin-2(ih)-oner for bruk som kardiotoniske midler. | |
| US4524149A (en) | 5-Alkanoyl-6-alkyl-2(1H)-pyridinones, their preparation and their cardiotonic use | |
| NO851066L (no) | Pyridinyl-2-pyrimidinaminer egnet som kardiotoniske midler samt fremstilling derav | |
| US4504482A (en) | [5(or 4)-(Pyridinyl)-2-pyrimidinyl]ureas and cardiotonic use thereof | |
| JPS5989662A (ja) | アルカノイルピリジノン類，それらの製造方法及びそれらからなる強心剤 | |
| NO834227L (no) | 2(1h)-pyridinonderivater og fremgangsmaate for deres fremstilling | |
| NO803911L (no) | 3-acylamino-5-(pyridinyl)-2(1h)-pyridinoner og fremgangsmaate til fremstilling derav | |
| US4451469A (en) | Selected 6-alkyl-and 4,6-dialkyl-2(1H)-pyridinones as cardiotonics | |
| NO821314L (no) | Pyrazolpyridinderivater og fremgangsmaate for deres fremstilling | |
| US4362734A (en) | 2-(Substituted-amino)-5-(pyridinyl-nicotinonitriles, and their cardiotonic use | |
| GB2058751A (en) | 5-(4-pyridinyl)-2(ih)pyridinones useful as cardiotonic agents | |
| NO803735L (no) | 6-(pyridinyl)pyridaziner og fremgangsmaate til deres fremstilling | |
| US4339584A (en) | Process for preparing 3-amino-5-(pyridinyl)-2(1H)-pyridinones via N-hydroxy-1,2-dihydro-2-oxo-5-(pyridinyl)-nicotinimidamide by reaction with polyphosphoric acid | |
| US4362735A (en) | 3-[(3-Oxo-1-butenyl)amino]-5-(pyridinyl)-2(1H)-pyridinones and their cardiotonic use | |
| US4503228A (en) | 2-(Pyridinyl)-4,5,6-pyrimidinetriamines | |
| KR790001308B1 (ko) | 3-아미노-5-(피리디닐)-2(1h)-피리디논류의 제조방법 | |
| NO810989L (no) | Imidazo(4,5-b)pyridin-derivater og fremstilling derav | |
| NO811420L (no) | 6-(pyridinyl)-4-substituert-3(2h)-pyridazinoner, egnet som kardiotoniske midler, og fremgangsmaate til deres fremstilling | |
| JPS6159625B2 (es) | ||
| NL8100922A (nl) | Nieuwe iminiumzouten, cardiotonische preparaten die deze iminiumzouten bevatten, alsmede werkwijze ter bereiding van nieuwe bipyridinonderivaten en werkwijze ter bereiding van 5-(cyano of carbamyl)-(3,4-bipyridin) -6(1h)-on. |